APRICUS BIOSCIENCES, INC.·4

Feb 28, 6:28 PM ET

Martin Steven Robert 4

4 · APRICUS BIOSCIENCES, INC. · Filed Feb 28, 2013

Insider Transaction Report

Form 4
Period: 2013-02-28
Martin Steven Robert
Chief Financial Officer
Transactions
  • Award

    Stock Option (right to buy)

    2013-02-28+2,5002,500 total
    Exercise: $2.67Exp: 2023-02-28Common Stock (2,500 underlying)
Footnotes (1)
  • [F1]The option is fully vested as of the date of grant.

Documents

1 file
  • 4
    rrd372369.xmlPrimary

    FORM 4